Skip to main content

Assenagon Asset Management S.A.

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1546007 SENNINGERBERG, N4

Position in HALO

as of Jun 30, 2026 · filed Jul 8, 2026
Position Value
$78,085,517
+$76,707,477 QoQ
Shares Held
997,643
+4578.9% QoQ
Ownership
0.841%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#2
of 18 holders
Holding Since
Dec 2020
17 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Assenagon Asset Management S.A. holds $1,943,463,989 across 69 Biotechnology names. HALO ranks #6 (4.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 HALO
Halozyme Therapeutics, Inc.
This page
997,643 $78,085,517

All Filings in HALO

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $78,085,517 997,643
2026-03-31 $1,378,040 21,322
2025-12-31 $4,851,320 72,085
2024-09-30 $222,091 3,880
2024-06-30 $2,301,222 43,950
2024-03-31 $2,149,531 52,840
2023-12-31 $4,627,650 125,207
2023-09-30 $2,717,700 71,144
2023-06-30 $12,327,427 341,764
2023-03-31 $17,299,458 452,984
2022-12-31 $9,028,379 158,671
2022-09-30 $551,029 13,936
2022-06-30 $613,184 13,936
2022-03-31 $988,744 24,793
2021-12-31 $1,000,826 24,890
2021-09-30 $927,015 22,788
2020-12-31 $10,045,648 235,206